PharmaCyte Biotech Inc (PMCB)

[rudygerner]

Janssen Pharmaceuticals will be our partner, imho, and here is why in chronological order:


First the NDA's were signed: http://pharmacyte.com/pharmacyte-seeks-to-solve-pancreas-puzzle-with-cell-in-a-box/ "... the company also is assessing the interest of big pharmas, and many have signed non-disclosure agreements."

Followed with a pr regarding Johnson & Johnson: http://ir.pharmacytebiotech.com/press-releases/detail/82/johnson-johnson-and-big-pharma-could-find-a-diabetes

PharmaCyte then hired a former J & J exec: http://ir.pharmacytebiotech.com/press-releases/detail/94/pharmacyte-biotech-appoints-former-johnson-johnson

KW then publicly posted on FB, (prior to taking his FB account private), "150 years and still going strong according to my Canadian colleagues. At PharmaCyte, they will soon outnumber the Americans."

Followed by Bavarian Nordic's recent expansion deal with Janssen: https://finance.yahoo.com/news/bavarian-expands-j-j-deal-084519162.html

Bavarian Nordic is the forerunner to Austrianova: http://ir.pharmacytebiotech.com/press-releases/detail/29/pharmacyte-biotechs-cancer-treatment-tumor

J & J is the parent company of Janssen Pharmaceuticals. J & J has the largest presence in Canada of all pharmaceutical companies: https://www.ic.gc.ca/eic/site/lsg-pdsv.nsf/eng/hn01768.html

Additionally, and most recently, PharmaCyte appointed Dr. Abecassis to their Board of Directors and Dr. Sher as their Chief Medical Officer.


After IND is filed we wait thirty days then the trial begins. According to my dd everything points to Janssen.